HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

AI Diagnostic Tool Accurately Detects Valvular Disorders Often Missed by Doctors

By HospiMedica International staff writers
Posted on 12 Oct 2023
Image: The AI tool detects cardiac diseases that doctors often miss (Photo courtesy of 123RF)
Image: The AI tool detects cardiac diseases that doctors often miss (Photo courtesy of 123RF)

Doctors generally use stethoscopes to listen for the characteristic lub-dub sounds made by heart valves opening and closing. They also listen for less prominent sounds that indicate problems with these valves. But the human body is full of other noises, like the flow of blood, stomach rumblings, and breath sounds, which can easily mask the signs of valvular heart disease (VHD). Research reveals that only 44% of VHD cases are caught through regular stethoscope check-ups. This leads to delayed diagnoses, worsening health conditions for patients, and huge costs for the healthcare system. To improve on this, researchers have now developed a new diagnostic tool that uses a short burst of audio data to accurately identify VHD.

Researchers at Stevens Institute of Technology (Hoboken, NJ, USA) used a contact microphone to take 10-second sound vibrations directly from a patient's chest. This data was then analyzed by an AI model adapted from algorithms normally used in speech processing to separate overlapping voices. In this case, the algorithm works to isolate the specific sounds associated with different types of heart valve diseases. The AI system can quickly identify up to five different types of valvular issues in a single patient, even if more than one condition is present.

The AI tool can detect VHD with 93% sensitivity and 98% specificity, substantially reducing undiagnosed cases and limiting false positives. The results are given in a simple 5-digit code made of ones and zeros, indicating the presence or absence of specific VHD. What sets this diagnostic tool apart from previously used neural networks to detect VHD is the use of accelerometers instead of more complex and cumbersome machines. Not only is this technique more accurate, but it also has the potential for further refinement. The team aims to extend their approach to identify other cardiovascular conditions and hopes to integrate this technology into medical practices nationwide, making it easier to diagnose cardiac disorders.

“Most cases of VHD are missed because of human error — so we brought in AI to help the human,” explained Negar Ebadi, the principal investigator of the project. “Our current goal is to collect more data so we can begin to classify diseases by severity — so instead of showing that you have a particular valvular disorder, we could give a grade out of 10 describing how far the disease has progressed.”

Related Links:
Stevens Institute of Technology 

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Hemostatic Agent
HEMOBLAST Bellows

Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more